These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34565290)

  • 21.
    Roberts MJ; Morton A; Donato P; Kyle S; Pattison DA; Thomas P; Coughlin G; Esler R; Dunglison N; Gardiner RA; Doi SA; Emmett L; Yaxley J
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):477-482. PubMed ID: 32696091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.
    Prasad V; Steffen IG; Diederichs G; Makowski MR; Wust P; Brenner W
    Mol Imaging Biol; 2016 Jun; 18(3):428-36. PubMed ID: 27038316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
    Shiiba M; Ishihara K; Kimura G; Kuwako T; Yoshihara H; Sato H; Kondo Y; Tsuchiya S; Kumita S
    Ann Nucl Med; 2012 Feb; 26(2):138-45. PubMed ID: 22069194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the accuracy of
    Paterson F; Nottage M; Kitchener M; Jarvis M; Reid J; Oakden-Rayner L
    J Med Imaging Radiat Oncol; 2022 Apr; 66(3):319-323. PubMed ID: 34250746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of androgen deprivation therapy on intraprostatic tumour volume identified on
    Chan J; Carver A; Brunt JN; Vinjamuri S; Syndikus I
    Br J Radiol; 2017 Mar; 90(1071):20160818. PubMed ID: 27993093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer.
    Behrendt FF; Lensing C; Keil S; Mottaghy FM; Verburg FA
    J Med Imaging Radiat Oncol; 2016 Aug; 60(4):498-505. PubMed ID: 27297449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion-weighted MRI,
    Kitajima K; Yamamoto S; Kawanaka Y; Nakanishi Y; Yamada Y; Go S; Kanematsu A; Kaida H; Yamakado K
    Hell J Nucl Med; 2020; 23(1):34-39. PubMed ID: 32222730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
    Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH
    J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artificial intelligence-based detection of lymph node metastases by PET/CT predicts prostate cancer-specific survival.
    Borrelli P; Larsson M; Ulén J; Enqvist O; Trägårdh E; Poulsen MH; Mortensen MA; Kjölhede H; Høilund-Carlsen PF; Edenbrandt L
    Clin Physiol Funct Imaging; 2021 Jan; 41(1):62-67. PubMed ID: 32976691
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Liu C; Liu T; Zhang N; Liu Y; Li N; Du P; Yang Y; Liu M; Gong K; Yang X; Zhu H; Yan K; Yang Z
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1852-1861. PubMed ID: 29717333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective evaluation of [
    Schwarzenböck SM; Eiber M; Kundt G; Retz M; Sakretz M; Kurth J; Treiber U; Nawroth R; Rummeny EJ; Gschwend JE; Schwaiger M; Thalgott M; Krause BJ
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2105-2113. PubMed ID: 27317482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective correlation of
    Onal C; Torun N; Oymak E; Guler OC; Reyhan M; Yapar AF
    Ann Nucl Med; 2020 Jun; 34(6):388-396. PubMed ID: 32221791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semiautomatically Quantified Tumor Volume Using
    Seifert R; Herrmann K; Kleesiek J; Schäfers M; Shah V; Xu Z; Chabin G; Grbic S; Spottiswoode B; Rahbar K
    J Nucl Med; 2020 Dec; 61(12):1786-1792. PubMed ID: 32332147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy.
    Hardcastle N; Hofman MS; Lee CY; Callahan J; Selbie L; Foroudi F; Shaw M; Chander S; Lim A; Chesson B; Murphy DG; Kron T; Siva S
    Radiat Oncol; 2019 Sep; 14(1):164. PubMed ID: 31488175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate- and High-Risk Prostate Cancer.
    Kuten J; Mabjeesh NJ; Lerman H; Levine C; Barnes S; Even-Sapir E
    Isr Med Assoc J; 2019 Feb; 21(2):100-104. PubMed ID: 30772960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of [
    Cysouw M; Bouman-Wammes E; Hoekstra O; van den Eertwegh A; Piet M; van Moorselaar J; Boellaard R; Dahele M; Oprea-Lager D
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):406-410. PubMed ID: 29559285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness.
    Chen J; Zhao Y; Li X; Sun P; Wang M; Wang R; Jin X
    Radiol Oncol; 2012 Sep; 46(3):179-88. PubMed ID: 23077456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.
    Ergül N; Yilmaz Güneş B; Yücetaş U; Toktaş MG; Çermik TF
    Clin Nucl Med; 2018 Dec; 43(12):e422-e427. PubMed ID: 30273204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-choline PET/computed tomography and clinical parameters in the detection of significant prostate cancer in patients with increased prostate-specific antigen levels and previous negative biopsies.
    Jiménez Londoño GA; García Vicente AM; Noriega Álvarez E; Pena Pardo FJ; Amo-Salas M; López Guerrero MA; Fúnez Mayorga F; Soriano Castrejón ÁM
    Nucl Med Commun; 2020 Jul; 41(7):674-681. PubMed ID: 32404644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.